HHS Makes Significant Changes to COVID-19 Daily Data Reporting Process

NHSN COVID-19 Reporting Module Being Retired as of Wednesday, July 15

The Department of Health and Human Services (HHS) today announced significant changes to the process for hospitals to fulfill the agency’s request for daily data reporting on bed capacity, utilization, personal protective equipment (PPE) and in-house laboratory testing data. The most significant changes are detailed below.

Reporting Options. The Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN) COVID-19 module will no longer be an option for daily data reporting as of July 15. Hospitals are asked to use one of the other reporting options to fulfill the data reporting request, including:

  • Reporting data to their state health departments, provided that their states have assumed responsibility for reporting hospital data to HHS. Such states have written authorization from their Assistant Secretary for Preparedness and Response (ASPR) regional administrator that they are assuming data reporting responsibilities. In turn, states should provide hospitals with written notification they are submitting data to HHS on their behalf.
     
  • Report to the HHS TeleTracking portal, an existing option for daily reporting. The TeleTracking portal also has been used for special data reporting requests related to high-impact funds distribution, as well as remdesivir distribution. For issues with accessing the TeleTracking portal or questions about the data, contact TeleTracking Technical Support at 1-877-570-6903.

Data Fields. HHS has made significant updates to the data fields it is asking for in daily reporting. For example, HHS is asking for information on both pediatric and adult patients, and is asking hospitals for information about their inventory of remdesivir.

The AHA strongly urges all hospitals to review the announcement and report the data to HHS as requested. HHS stressed in the announcement the importance of reporting the requested data on a daily basis to inform the Administration’s ongoing response to the pandemic, including the allocation of supplies, treatments and other resources. In addition, the agency notes it will no longer ask for one-time requests for data to aid in the distribution of remdesivir or any other treatments or supplies. This means that the daily reporting is the only mechanism used for the distribution calculations

Related Resources

Letter/Comment
The Honorable Mark Warner United States Senate 703 Hart Senate Office Building Washington, DC 20510 The Honorable Tim Scott United States Senate 104 Hart…
Special Bulletin
The White House Aug. 3 issued an executive order on “improving rural health and telehealth access.” The order includes directives to: launch a new payment…
Letter/Comment
The Honorable Seema Verma Administrator Centers for Medicare & Medicaid Services Hubert H. Humphrey Building 200 Independence Avenue, S.W., Room 445-G…
Special Bulletin
The Department of Health and Human Services (HHS) yesterday updated its guidance and frequently asked questions (FAQs) regarding the agency’s request for daily…
Case Studies
Public
In Chicago, the COVID-19 pandemic has ravaged communities of color, disproportionately affecting Black residents. They represent only 30% of the population,…
Special Bulletin
Public
Together, the AHA, the American Medical Association (AMA) and American Nurses Association (ANA) today released a public service announcement (PSA) urging the…